Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer

  • The PLOS ONE Staff

In the article title, “Lap atinib” should be displayed as “Lapatinib.” The correct title is: Yes1 signaling mediates the resistance to Trastuzumab/Lapatinib in breast cancer. The correct citation is: Takeda T, Yamamoto H, Kanzaki H, Suzawa K, Yoshioka T, Tomida S, et al. (2017) Yes1 signaling mediates the resistance to Trastuzumab/Lapatinib in breast cancer. PLoS ONE 12(2): e0171356. doi:10.1371/journal.pone.0171356. The publisher apologizes for the error.

Reference

  1. 1. Takeda T, Yamamoto H, Kanzaki H, Suzawa K, Yoshioka T, Tomida S, et al. (2017) Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer. PLoS ONE 12(2): e0171356. pmid:28158234

Citation: The PLOS ONE Staff (2017) Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer. PLoS ONE 12(3): e0174493. https://doi.org/10.1371/journal.pone.0174493

Published: March 16, 2017

Copyright: © 2017 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.